US Insulin Pump Market Size was valued at USD 2.7 Billion in 2022. The Insulin Pump market industry is projected to grow from USD 3.17 Billion in 2023 to USD 11.52 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 17.50% during the forecast period (2023 - 2032). The rising prevalence of diabetes, the growing preference for insulin pumps among patients, and the growing awareness of insulin pumps for better health are the main market drivers anticipated to propel the Insulin Pump market in the United States.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The market's growth in the popularity of wearable insulin pumps is influencing its growth. Traditional insulin pumps were typically connected to external devices and carried in a separate pouch, but wearable pumps are designed to integrate seamlessly into the user's lifestyle. These devices are compact, discreet, and can be worn directly on the body, offering greater convenience and comfort for individuals with diabetes. The shift towards wearable insulin pumps reflects a growing demand for solutions that prioritize patient comfort and encourage consistent insulin therapy adherence. Moreover, wireless connectivity enables seamless communication with other devices, such as smartphones and continuous glucose monitoring systems, providing users with real-time insights and control over their diabetes management.
Furthermore, the US is increasingly adopting hybrid closed-loop systems called artificial pancreas systems. These systems join insulin pumps with continuous glucose monitoring devices, creating a closed-loop feedback system. The CGM continuously measures glucose levels, and the integrated algorithm automatically adjusts insulin delivery in response to these real-time readings. This closed-loop functionality helps maintain blood glucose levels within a target range without constant manual intervention. As a result, individuals with diabetes experience improved stability in glycemic control and a reduced risk of complications. The convenience and enhanced automation offered by hybrid closed-loop systems contribute to better patient compliance and overall satisfaction. Thus driving the Insulin Pump market revenue.
The US Insulin Pump market segmentation, based on type, includes Patch pumps and Tethered pumps. The patch pumps segment mostly dominated the market. It represents an innovative insulin delivery system that adheres directly to the skin, offering discreet and convenient administration for individuals managing diabetes. These pumps provide a viable alternative to traditional insulin pump options, contributing to the market's diversification of insulin delivery methods. Their user-friendly design and potential benefits make patch pumps an increasingly relevant segment in the diabetes management landscape.
The US Insulin Pump market segmentation, based on product, includes MiniMed, Accu-Chek, Tandem, Omnipod, My Life Omnipod, and Others. The MiniMed category generated the most income. It is a leading insulin pump brand that offers innovative solutions for diabetes management. MiniMed insulin pumps contribute significantly to the market's growth because they are renowned for their user-friendly design and advanced features. With a focus on patient convenience and improved outcomes, MiniMed remains a key player in shaping the landscape of insulin pump products in the United States.
The US Insulin Pump market segmentation, based on accessories, includes insulin reservoirs or cartridges, Insulin set insertion devices, and batteries. The insulin reservoirs or cartridges segment generated the most income. It plays a pivotal role in efficiently delivering Insulin to patients using insulin pumps. Understanding the market dynamics and preferences related to insulin reservoirs or cartridges is essential for manufacturers and healthcare providers to meet the specific needs of individuals managing diabetes through insulin pump therapy.
The US Insulin Pump market segmentation, based on end-users, includes Hospitals and clinics, Homecare and Laboratories. The hospitals & clinics category had the most income. As key stakeholders in diabetes management, hospitals, and clinics serve as crucial settings for the administration, monitoring, and education related to insulin pump therapy. This segment reflects the integral role of healthcare facilities in facilitating access to advanced diabetes care through insulin pump solutions in the US market.
Figure 1: US Insulin Pump Market, by End-user, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
With a rising prevalence of diabetes, the demand for insulin pumps continues to grow, driven by innovations in technology and a shift towards more convenient and efficient diabetes management. It is characterized by a competitive landscape, with key players introducing innovative features such as continuous glucose monitoring and smartphone integration. Additionally, favorable reimbursement policies and increasing awareness among healthcare professionals and patients contribute to market expansion. The US insulin pump market is poised for further growth, fueled by ongoing research and development, emphasizing user-friendly designs and enhanced connectivity. As the industry continues to address the evolving needs of diabetes management, collaborations between manufacturers and healthcare providers are likely to play a pivotal role in shaping the market's trajectory.
Insulin Pump Key Market Players & Competitive Insights
Leading market players are investing majorly in research and development to spread their product lines, which will help the Insulin Pump market grow even more. The participants are also undertaking various strategic activities to spread their footprint with new market developments, including product launches, contractual agreements, mergers and acquisitions, major investments, and collaboration with other organizations. The Insulin Pump industry must offer cost-effective items to spread and survive in a competitive and rising market climate.
The players in the Insulin Pump market are attempting to raise market demand by investing in research and development operations, including Medtronic PLC, Hoffmann-La Roche Ltd., Tandem Diabetic Care, Inc., Insulet Corporation, Ypsomed, Cellenovo, Sooil Development, Valeritas, Inc., and Jingasu Delfu Co., Ltd.
Key Companies in the Insulin Pump market include
Insulin Pump Industry Developments
June 2022: Diabeloop, a leading company in therapeutic AI, and SOOIL Development Company, a leading company in superior diabetes therapy, Proposed an agreement for the development at the American Diabetes Association Scientific Sessions. It is anticipated that clinical trials will be established to spread their cooperation and provide access to their goods to as many plepeople as possible through new innovative products.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 2.7 Billion |
| Market Size 2023 | USD 3.17 Billion |
| Market Size 2032 | USD 11.52 Billion |
| Compound Annual Growth Rate (CAGR) | 17.50% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Product, Accessories, End-user, and Region |
| Countries Covered | US |
| Key Companies Profiled | Medtronic PLC, Hoffmann-La Roche Ltd., Tandem Diabetic Care, Inc., Insulet Corporation, Ypsomed, Cellenovo, Sooil Development, Valeritas, Inc., and Jingasu Delfu Co., Ltd |
| Key Market Opportunities | Growth in awareness among healthcare professionals and people about the benefits of insulin pump therapyRise in the focus on the prevention of diabetes globally |
| Key Market Dynamics | Growth in the adoption of closed-loop systemsRising preference among patients for insulin pumps |
Frequently Asked Questions (FAQ) :
The US Insulin Pump market size was valued at USD 2.7 Billion in 2022.
The market is projected to grow at a CAGR of 17.50% during the forecast period, 2023-2032.
The key players in the market are Medtronic PLC, Hoffmann-La Roche Ltd., Tandem Diabetic Care, Inc., Insulet Corporation, Ypsomed, Cellenovo, Sooil Development, Valeritas, Inc., and Jingasu Delfu Co., Ltd.
The patch pumps category dominated the market in 2022.
The MiniMed category had the largest share in the market.
The insulin reservoirs or cartridges category had the largest share of the market.
The hospitals & clinics category had the largest share of the market.
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
